Tylosin Base Injection

Riik: Uus-Meremaa

keel: inglise

Allikas: Ministry for Primary Industries

Osta kohe

Toote omadused Toote omadused (SPC)
01-02-2022
Avaliku hindamisaruande Avaliku hindamisaruande (PAR)
01-12-2018

Toimeaine:

tylosin

Saadav alates:

Elanco New Zealand

INN (Rahvusvaheline Nimetus):

tylosin

Koostis:

tylosin 200 g/litre

Terapeutiline ala:

Antibiotic

Volitamisolek:

ACVM Registered

Loa andmise kuupäev:

2009-11-04

Toote omadused

                                WARNING
RESTRICTED VETERINARY MEDICINE
KEEP OUT OF REACH OF CHILDREN
FOR ANIMAL TREATMENT ONLY
TYLOSIN BASE INJECTION
TYLOSIN INJECTION
100ML
Glass Vial and Flexipack Label
Issue date: 26 January 2022
_The information above this line is not included in the label _
CRITICALLY IMPORTANT ANTIBIOTIC
ACTIVE CONSTITUENT
Each mL contains 200mg Tylosin Base (20% w/v). Also contains Benzyl
Alcohol < 5%.
INDICATIONS
Tylosin Base Injection is indicated in the treatment of systemic
infections caused by bacteria sensitive to
tylosin in cattle, calves, sheep, goats and pigs. Tyloject possesses a
wide range of antibiotic activity and is
active against gram positive bacteria including Staphylococci,
Streptococci, Corynebacteria spp. and
Erysipelothrix rhusiopathiae (insidiosa). It is also active against
certain gram negative bacteria, e.g.
Campylobacter coli and certain spirochaetes.
CATTLE
Respiratory infections caused by Pasteurella multocida, Foot-rot
(necrotic pododermatitis) and diphtheria
caused by Fusobacterium necrophorum, metritis caused by
Corynebacterium pyogenes, and acute mastitis
caused by S. uberis and S. aureus.
SHEEP AND GOATS
The treatment of the early stages of the peracute and acute forms of
Contagious agalactia caused by
Mycoplasma agalactiae and Caprine pleuropneumonia caused by Mycoplasma
mycoides var capri (M.
capri).
PIGS
The treatment of porcine proliferative enteropathy associated with
Lawsonia intracellularis, erysipelas caused
by Erysipelothrix rhusiopathiae, arthritis caused by Mycoplasma
hyosynoviae, and pneumonia caused by
Mycoplasma hyopneumoniae.
DIRECTIONS FOR USE
READ PACKAGE INSERT AND UNIT CARTON PRIOR TO USE
By intramuscular injection into the anterior half of the neck of pigs,
goats, sheep and cattle.
Also by slow intravenous injection in cattle only.
CATTLE
0.5–1mL/20kg bwt (5–10mg/kg) daily for up to 5 days
SHEEP AND GOATS
1mL/20kg bwt (10mg/kg) daily for up to 5 days
PIGS
0.5–1mL/20kg bwt (5–10mg/kg) daily for up to 3 days
08/03/2022
WARNING
RESTRICTED VETERINARY MEDICINE
KEEP O
                                
                                Lugege kogu dokumenti
                                
                            

Otsige selle tootega seotud teateid